AI is about to change healthcare. These 110 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For someone considering M/I Homes today, the core belief is that a cyclical homebuilder with seasoned leadership can still create value even when earnings cool. The latest results show revenue essentially flat for 2025 but a clear compression in net income and margins, so in the short term the story tilts more toward profitability pressure than top-line momentum. That softening earnings profile slightly dulls earlier catalysts tied to resilient demand and pricing, and it puts more focus on how efficiently the company converts sales into profit. At the same time, management has continued to lean into buybacks, completing another US$30.37 million as earnings slowed, which reinforces capital return as part of the thesis but also tightens financial flexibility if conditions stay tougher for longer.
However, the earnings slowdown raises one risk that newer shareholders may be underestimating. Despite retreating, M/I Homes' shares might still be trading 21% above their fair value. Discover the potential downside here.Explore 2 other fair value estimates on M/I Homes - why the stock might be worth just $157.00!
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com